ABX-464 Uses, Dosage, Side Effects and more
ABX-464 is under investigation in clinical trial NCT03905109 (Safety Evaluation of ABX464 in Patients With Moderate to Severe Active Crohn's Disease).
| Trade Name | ABX-464 |
| Generic | ABX-464 |
| Type | |
| Formula | C16H10ClF3N2O |
| Weight | Average: 338.71 Monoisotopic: 338.0433751 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
